0
Amicus Therapeutics, Inc.
- 501-1000 Employees
- Based in Philadelphia, Pennsylvania
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic…More
Amicus Therapeutics, Inc.
Most Recent Responsibility Report
Amicus Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
-
2023 Environmental, Social,and Governance Report View Environmental, Social,and Governance Report Download -
2021 Environmental, Social, and Governance Report View Environmental, Social, and Governance Report Download -
2020 Environmental, Social, and Governance Report View Environmental, Social, and Governance Report Download
Our service enables potential investors to review the most recent and archived Amicus Therapeutics, Inc. Sustainability Report, Amicus Therapeutics, Inc. Corporate Social Responsibility Report, Amicus Therapeutics, Inc. CSR Report, Amicus Therapeutics, Inc. Corporate Responsibility, Amicus Therapeutics, Inc. CR Report, Amicus Therapeutics, Inc. Citizenship Report, Amicus Therapeutics, Inc. ESG Report, and Amicus Therapeutics, Inc. Environmental Report online.